In a commentary published in STAT, NPC Chief Science Officer and Executive Vice President Robert Dubois, MD, PhD, outlines some creative thinking behind how we could innovate payment models to finance curative therapies for cancers and other rare diseases.

The U.S. Food and Drug Administration took significant steps to modernize how health care information is communicated. The two final guidance documents address communications questions as well as many concerns raised by NPC through our longstanding research in this area and in public testimony and comments.

NPC is pleased to support the Health Affairs Council on Health Care Spending and Value, which will further advance the all-important health spending dialogue.